These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27270858)

  • 1. Comparing clinical responses and the biomarkers of BDNF and cytokines between subthreshold bipolar disorder and bipolar II disorder.
    Wang TY; Lee SY; Chen SL; Chang YH; Wang LJ; Chen PS; Chen SH; Chu CH; Huang SY; Tzeng NS; Li CL; Chung YL; Hsieh TH; Lee IH; Chen KC; Yang YK; Hong JS; Lu RB
    Sci Rep; 2016 Jun; 6():27431. PubMed ID: 27270858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of add-on low-dose dextromethorphan plus valproic acid in bipolar disorder.
    Chen SL; Lee SY; Chang YH; Chen PS; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1753-9. PubMed ID: 25262178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of add-on low-dose memantine on cytokine levels in bipolar II depression: a 12-week double-blind, randomized controlled trial.
    Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Wang TY; Yeh TL; Yang YK; Hong JS; Lu RB
    J Clin Psychopharmacol; 2014 Jun; 34(3):337-43. PubMed ID: 24717258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Add-On Memantine Treatment for Bipolar II Disorder Comorbid with Alcohol Dependence: A 12-Week Follow-Up Study.
    Lee SY; Wang TY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Chen KC; Yang YK; Hong JS; Lu RB
    Alcohol Clin Exp Res; 2018 Jun; 42(6):1044-1050. PubMed ID: 29656414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype variant associated with add-on memantine in bipolar II disorder.
    Lee SY; Chen SL; Chang YH; Chen SH; Chu CH; Huang SY; Tzeng NS; Wang CL; Wang LJ; Lee IH; Yeh TL; Yang YK; Hong JS; Lu RB
    Int J Neuropsychopharmacol; 2014 Feb; 17(2):189-97. PubMed ID: 24103632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation's Association with Metabolic Profiles before and after a Twelve-Week Clinical Trial in Drug-Naïve Patients with Bipolar II Disorder.
    Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Wang TY; Yeh TL; Yang YK; Hong JS; Lu RB
    PLoS One; 2013; 8(6):e66847. PubMed ID: 23826157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Differential Levels of Inflammatory Cytokines and BDNF among Bipolar Spectrum Disorders.
    Wang TY; Lee SY; Chen SL; Chung YL; Li CL; Chang YH; Wang LJ; Chen PS; Chen SH; Chu CH; Huang SY; Tzeng NS; Hsieh TH; Chiu YC; Lee IH; Chen KC; Yang YK; Hong JS; Lu RB
    Int J Neuropsychopharmacol; 2016 Aug; 19(8):. PubMed ID: 26865313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Add-on memantine may improve cognitive functions and attenuate inflammation in middle- to old-aged bipolar II disorder patients.
    Lu RB; Wang TY; Lee SY; Chang YH; Chen SL; Tsai TY; Chen PS; Huang SY; Tzeng NS; Lee IH; Chen KC; Yang YK; Hong JS
    J Affect Disord; 2021 Jan; 279():229-238. PubMed ID: 33069121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of plasma brain-derived neurotrophic factor and metabolic profiles in drug-naïve patients with bipolar II disorder after a twelve-week pharmacological intervention.
    Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang CL; Wang LJ; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
    Acta Psychiatr Scand; 2015 Feb; 131(2):120-8. PubMed ID: 25131388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder.
    Kauer-Sant'Anna M; Kapczinski F; Andreazza AC; Bond DJ; Lam RW; Young LT; Yatham LN
    Int J Neuropsychopharmacol; 2009 May; 12(4):447-58. PubMed ID: 18771602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DRD2/ANKK1 gene is associated with response to add-on dextromethorphan treatment in bipolar disorder.
    Lee SY; Chen SL; Chang YH; Chen SH; Chu CH; Huang SY; Tzeng NS; Wang CL; Lee IH; Yeh TL; Yang YK; Lu RB
    J Affect Disord; 2012 May; 138(3):295-300. PubMed ID: 22326841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The correlation between plasma brain-derived neurotrophic factor and cognitive function in bipolar disorder is modulated by the BDNF Val66Met polymorphism.
    Lee SY; Wang TY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Chen KC; Yang YK; Yang YH; Lu RB; Chen CS
    Sci Rep; 2016 Dec; 6():37950. PubMed ID: 27905499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder.
    Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Yeh TL; Yang YK; Lu RB; Hong JS
    J Psychiatr Res; 2013 Oct; 47(10):1343-8. PubMed ID: 23870798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    McIntyre RS; Mancini DA; Srinivasan J; McCann S; Konarski JZ; Kennedy SH
    Can J Clin Pharmacol; 2004; 11(2):e218-26. PubMed ID: 15520475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania.
    Berk M; Ng F; Wang WV; Tohen M; Lubman DI; Vieta E; Dodd S
    J Affect Disord; 2008 Sep; 110(1-2):126-34. PubMed ID: 18280579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum protein levels of brain-derived neurotrophic factor and tropomyosin-related kinase B in bipolar disorder: effects of mood stabilizers.
    Huang TL; Hung YY; Lee CT; Chen RF
    Neuropsychobiology; 2012; 65(2):65-9. PubMed ID: 22222435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.
    Suppes T; Brown E; Schuh LM; Baker RW; Tohen M
    J Affect Disord; 2005 Dec; 89(1-3):69-77. PubMed ID: 16253344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.